July 3 press releaseI just re-read the July 3rd press release. I get the impression that Don must feel very strongly that RVX is going to be making money soon because of the commitments to Eastern in terms of annual interest commitments and loss of patents to Eastern.
I also get the impression that Eastern/KD must feel that the RVX patents are worth a huge amount of money (along with tax losses).
As I understand it Don/RVX has until Aug 28, 2017 to pay out whatever they owe on the Citi loan and this, to me, means RVX had better have positive cash flow or some sort of purchase like a CVR long before 2017 or he will lose it all.
I guess Don and the board had no choice but to get the extra $30,000,000 OR they could have walked away from RVX and let Eastern have it. However, I'm sure NGN would have fought this or found a solution.
Once again this re-inforces the extremely high level of belief at RVX, NGN and Eastern that rvx-208 works and that the probability of success in the ph2c trial is extremely high and that there are many applications for rvx-208 in treating many diseases beyond cardio-vascular diseases.
When I first started posting here a few month back I had my doubts about Don's ability to move this ahead. WELL IT FEELS GREAT TO HAVE BEEN PROVEN WRONG. I think things are going to move forward quickly...at least as fast as science permits IMO.
My guess is that we'll hear more posiitive information soon.
Cheers
Toinv